U.s. food and drug administration approves aptargroup's activ-blister packaging solution for oral solid dose hiv prevention medicine

Aptargroup, inc. announced that its activ-blister™ packaging solution for oral solid dose drug delivery was recently approved by the u.s. food and drug administration (fda) for a hiv prevention medicine. the system protects oral solid drug products with a 3-phase activ-polymer™ solution that is fully integrated into the blister package. this 3-phase activ-polymer™ technology, which can be customized specifically for the drug developer’s formulation, offers a broad spectrum of specific drug protection including moisture adsorption, and oxygen and odor scavenging. the technology can also scavenge volatile organic compounds (vocs) and emit aromas.
ATR Ratings Summary
ATR Quant Ranking